Nisa Investment Advisors
OMIC

Nisa Investment Advisors’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Nisa Investment Advisors’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3
Closed – – 2768
2022
Q4 		$0 Sell
3
-170
-98% -$11.4K ﹤0.01% 2769
2022
Q3 		$14K Hold
173
– – ﹤0.01% 2129
2022
Q2 		$20K Buy
+173
New +$20.3K ﹤0.01% 2053

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nisa Investment Advisors's OMIC Position: Q1 2023 in Review

Nisa Investment Advisors sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q1 2023, closing a stake of 3 shares.

Nisa Investment Advisors first reported a position in OMIC in Q2 2022 and held it in 3 quarters. The position peaked at $20K in Q2 2022. 66 funds tracked by Wall St. Rank hold OMIC as of Q1 2023.

  • Nisa Investment Advisors reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Nisa Investment Advisors sold 3 Singular Genomics Systems, Inc. Common Stock shares in Q1 2023.
  • Nisa Investment Advisors first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
  • Nisa Investment Advisors's Singular Genomics Systems, Inc. Common Stock position peaked at $20K in Q2 2022.
  • 66 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q1 2023.

Based on Nisa Investment Advisors's 13F filing for Q1 2023, filed 2 May 2023.